Leucocytosis following Transfusion with Leucodepleted Red Cells to Non-Bleeding Critically Ill Patients

Abstract

Previous studies have shown that transfusion of non-leucodepleted red blood cells can cause leucocytosis in recipients. A small study suggested that pre-storage leucodepletion removed this phenomenon, but has not been further substantiated. We explored whether recipient leucocytosis occurs when leucodepleted red blood cells were transfused to non-bleeding intensive care patients. We used routinely collected data for 95 transfusions in 54 patients. Overall, no leucocytosis was found on the first routine blood sample following transfusion (mean change 0.6 × 10⁹/L; 95% confidence interval - 0.2 to 1.3; p=0.145). However, for the 32 transfusions in patients with normal pre-transfusion leucocyte count there was a clinically small but statistically significant leucocytosis following transfusion, unlikely to have occurred by chance (mean change 1.5 × 10⁹/L; 0.5 to 2.5; p=0.005). No significant change was observed in patients with pre-transfusion leucocytosis. We found no relation between leucocytosis and storage age of red cells. Our data suggest that transfusions with leucodepleted red cells can increase leucocyte counts in recipients. The mechanism of this effect and its clinical importance are uncertain.

Keywords

leucocytosis blood transfusion critical illness

References

McLellan

McClelland

Walsh

. Anaemia and red blood cell transfusion in the critically ill patient. Blood Rev 2003;17: 195–208.

Zaki

Fouda

Eldeen

OA Sharaf

. Extracellular accumulation of bioactive substances; interleukin-1beta (IL-1beta) and plasminogen activator inhibitor-1 (PAI-1) in stored blood units and relation to bacterial contamination. Hematol 2006;11: 301–05.

Fenwick

Cameron

Naiman

. Blood transfusion as a cause of leucocytosis in critically ill patients. Lancet 1994;344: 855–56.

Izbicki

Rudensky

Na'Amad

. Transfusion-related leukocytosis in critically ill patients. Crit Care Med 2004;32: 439–42.

Walsh

Garrioch

Maciver

. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004;44: 1405–11.

Hebert

Wells

Blajchman

. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group? N Engl J Med 1999; 340: 409–17.

Vincent

Baron

Reinhart

. Anemia and blood transfusion in critically ill patients. JAMA 2002;288: 1499–507.

Corwin

Gettinger

Pearl

. The CRIT Study: Anemia and blood transfusion in the critically ill—current clinical practice in the United States. Crit Care Med 2004;32: 39–52.

Vamvakas

. WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003;43: 963–73.

10.

Vamvakas

. White-blood-cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational ‘before-and-after’ studies. Vox Sang 2004;86: 111–19.

11.

Hebert

Fergusson

Blajchman

. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003;289: 1941–49.

12.

Llewelyn

Taylor

Todd

. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 2004;44: 489–500.